BIIB

BIOGEN INC.

SEC CIK 875045
$199.96 +13.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
36
Most recent

Insider transaction history

Form 4 filings for BIIB, newest first
View on SEC EDGAR ↗
BIIB
Option exercise Keeney Adam · Head of Corporate Development · Option exercise · May 1, 2026
+$0
939 sh
BIIB
Tax withholding Keeney Adam · Head of Corporate Development · Tax withholding · May 1, 2026
−$85.1K
455 sh @ $187
BIIB
Option exercise Godbout Sean · Chief Accounting Officer · Option exercise · Apr 1, 2026
+$0
181 sh
BIIB
Tax withholding Godbout Sean · Chief Accounting Officer · Tax withholding · Apr 1, 2026
−$9.9K
54 sh @ $184
BIIB
Buy Murphy Nicole · Head of Pharm Ops and Tech · Open-market purchase · Feb 12, 2026
+$585
3 sh @ $195
BIIB
Sell Singhal Priya · Head of Development · Open-market sale · Feb 9, 2026
−$531.5K
2,660 sh @ $200
BIIB
Tax withholding Singhal Priya · Head of Development · Tax withholding · Feb 6, 2026
−$212.4K
1,056 sh @ $201
BIIB
Tax withholding Singhal Priya · Head of Development · Tax withholding · Feb 6, 2026
−$284.1K
1,412 sh @ $201
BIIB
Option exercise Murphy Nicole · Head of Pharm Ops and Tech · Option exercise · Feb 6, 2026
+$0
2,102 sh
BIIB
Tax withholding Murphy Nicole · Head of Pharm Ops and Tech · Tax withholding · Feb 6, 2026
−$204.6K
1,017 sh @ $201
BIIB
Option exercise Murphy Nicole · Head of Pharm Ops and Tech · Option exercise · Feb 6, 2026
+$0
1,940 sh
BIIB
Tax withholding Murphy Nicole · Head of Pharm Ops and Tech · Tax withholding · Feb 6, 2026
−$183.9K
914 sh @ $201
BIIB
Option exercise Murphy Nicole · Head of Pharm Ops and Tech · Option exercise · Feb 6, 2026
+$0
4,683 sh
BIIB
Tax withholding Murphy Nicole · Head of Pharm Ops and Tech · Tax withholding · Feb 6, 2026
−$283.3K
1,408 sh @ $201
BIIB
Option exercise Kramer Robin · Chief Financial Officer · Option exercise · Feb 6, 2026
+$0
789 sh
BIIB
Tax withholding Kramer Robin · Chief Financial Officer · Tax withholding · Feb 6, 2026
−$54.9K
273 sh @ $201
BIIB
Option exercise Kramer Robin · Chief Financial Officer · Option exercise · Feb 6, 2026
+$0
703 sh
BIIB
Tax withholding Kramer Robin · Chief Financial Officer · Tax withholding · Feb 6, 2026
−$41.6K
207 sh @ $201
BIIB
Option exercise Kramer Robin · Chief Financial Officer · Option exercise · Feb 6, 2026
+$0
3,511 sh
BIIB
Tax withholding Kramer Robin · Chief Financial Officer · Tax withholding · Feb 6, 2026
−$213.9K
1,063 sh @ $201

About BIIB insider activity

This page tracks every recent Form 4 filed for BIOGEN INC. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is BIIB insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for BIOGEN INC. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.